Itch without a rash Clinical Advisor Medications include rosiglitazone ( Avandia ), metformin, lovastatin, captopril, and atenolol. Other treatment includes prednisone (oral, topical, ...

FDA Asks For Restraint On Drug Safety Worries Forbes (blog) ... resulted in Novartis' bowel drug Zelnorm being yanked, and it was another meta-analysis by Nissen that raised concerns about GlaxoSmithKline's Avandia . ...

EMA poses new questions on Avandia FiercePharma European regulators are gathering more info about Avandia safety. The European Medicines Agency convened an unexpected meeting of its advisory committee ... Bahrain alarm over diabetes drug Avandia

GlaxoSmithKline sells Croatian research center to Galapagos, names new CFO and ... The Pharma Letter Added to which, the European Medicines Agency (EMEA) gave an update to its consideration of the firm's diabetes drug Avandia (rosiglitazone), which has been ...

EU agency poses new questions on Glaxo's Avandia Reuters L) additional questions about its diabetes drug Avandia before giving a final verdict later this month on whether it should stay on the market. ...

CHMP Meets To Discuss Avandia , Pandemrix, To Question GlaxoSmithKline Wall Street Journal ... said Wednesday that it met to discuss the ongoing benefit-risk review of the rosiglitazone-containing medicines Avandia , Avandamet and Avaglim, ...

Telegraph.co.uk Shares of GlaxoSmithKline Down on UK Avandia Row (GSK) Comtex Smartrend ... to $38.47 Tuesday, following a recommendation by UK regulators that the company's controversial diabetes drug Avandia be removed, reports MarketWatch. ... Avandia : To be pulled out from market Heart attack risk of diabetes drug: Experts call for Avandia to be withdrawn Glaxo's Avandia should be pulled from market: BMJ - -

Idenix, China Sky tumble; drug indexes slip MarketWatch According to reports, UK regulators have recommended removing Glaxo's controversial diabetes drug Avandia from the UK market over concerns it can aggravate ...

Reuters Africa In Light European Trading, Markets Make Modest Gains New York Times Shares of the drug maker GlaxoSmithKline fell amid concerns about its Avandia drug. Its stock fell 1.5 percent after British regulators said the company's ... Utilities push Europe shares higher; Glaxo falls Closing stock market indices outside the US European shares edge higher; utilities in demand -

Health Jackal Diabetes Drug Avandia as Safe as Actos: Study FOXNews GlaxoSmithKline's diabetes drug Avandia was no riskier to the heart than a rival, US researchers said on Tuesday, a finding that contradicts earlier studies ... Heart risk from diabetes drug Actos as great as from Avandia , study finds Avandia : Less Risky in Younger, Healthier Patients? FDA Reviewer, Expert Panelists, Not Happy with Avandia Letter - -